CCRM in the News 2020

CCRM in the News 2020

A sampling of media coverage that profiles or mentions CCRM

Toronto accelerator fosters made-in-Canada approach to cell therapy. Canadian Manufacturing, October 23, 2020.

Cell Therapy Scale-Up Strategies For Commercial Success. Biosimilar Development, October 5, 2020.

Canada can become a leader in regenerative medicine. Innovating Canada, September 25, 2020

Robust Process Development For cGMP Manufacturing of Cell Therapies. Cell & Gene, September 24, 2020.

Practical Tips To Develop A Lentivirus Packaging Cell Line. Cell & Gene, September 9, 2020.

Platform Cell and Gene Therapy Media Development. Cell & Gene, September 9, 2020.

Panel of Canadian regenerative medicine leaders tackle translation and commercialization challenges in panel discussion. Medicine by Design website, August 13, 2020.

Critical planning for regenerative medicine therapies needs to happen now to ensure smooth adoption into health system, paper urges. Medicine by Design website, August 13, 2020.

Securing future of regenerative medicine in Victoria [Australia]The National Tribune, August 10, 2020.

Pluripotent Stem Cell Expansion And Scale-Up. Cell & Gene, August 5, 2020.

Improving Lentiviral Vector Downstream Processing Workflows. Cell & Gene, August 5, 2020.

Notch Therapeutics Appoints David Main as President and CEO to Advance the Company’s Novel Gene-Edited, iPSC-Derived Immune Cell Therapeutics. Canadian Life Sciences Database, July 20, 2020.

U of T spin-off Empirica Therapeutics acquired by U.S. firm. U of T News, July 15, 2020.

Innovation Economy Council: Advanced mfg booming in OntarioCanadian Manufacturing, July 9, 2020.

Professor’s startup acquired by U.S. firmBrighter World (McMaster University), June 26, 2020.

Medicine by Design Launches Translation Talks. Medicine by Design website, June 16, 2020.

The New Wave of InnovationContract Pharma, June 4, 2020.

The Short Report. Research Money, May 20, 2020.

Report: Startups Could Fuel The Recovery Of Canada’s Economy. BetaKit, April 28, 2020.

Tech startups are the foundation of Canada’s economic revival and will need stimulus to surviveThe Globe and Mail, April 28, 2020.

Master iPSC bank to be produced by CCRM and panCELLa. RegMedNet, April 23, 2020.

panCELLa, CCRM collaborate to benefit academia and industry. Contract Pharma, April 21, 2020.

Avectas collaborates with CCRM on cell engineering tech. BioPharma Reporter, March 4, 2020.

Advancing Platelet-Based Therapeutics for PatientsGenetic Engineering & Biotechnology News, February 11, 2020

Reflections On An Unprecedented Decade In The Cell And Gene Therapy Field. Cell & Gene, February 4, 2020

Why stem cells could be the medical innovation of the century. World Economic Forum website, January 16, 2020

CCRM helping to solve the big problems in regenerative medicineGenetic Engineering & Biotechnology News, January 3, 2020

CCRM in the News 2019

A sampling of media coverage that profiles or mentions CCRM

Measure Twice, Treat Once: Navigating the Regulatory Landscape of Assay Development to Ensure High-Quality CGT Products. BioProcess International, December 16, 2019.

Medicine by Design draws hundreds to annual research event, praise by federal innovation minister. U of T News, December 9, 2019.

Biotech ecosystems aim to start the talent pipeline early in a student’s career. The Globe and Mail, November 14, 2019.

The Innovations Arms Race: Commercializing Life Sciences in Toronto. Life Sciences Career Development Society website. November 11, 2019.

NGen Manufacturing Program Supports $4.2M Project. Mentor Works, November 6, 2019.

Allogene sets sights on iPS cell-based allogeneic therapies via Notch partnership. BioCentury, November 5, 2019.

Allogene, Notch partner to develop iPSC-derived blood cancer therapies. Genetic Engineering & Biotechnology News, November 5, 2019.

Forward thinking – evolving the cell and gene therapy industry: Modern CAR T-cell process addresses future demand. BioProcess International, October 28, 2019.

Special report on cell biology: Making bioprogress. DDNews, October 5, 2019.

Out of order: Check your ego. DDNews, September 2019.

Ontario continues to establish its role as a world leader in regenerative medicine. Clinical Trials Ontario website, September 12, 2019.

Special report on stem cells: Hope over hype. DDNews, September 10, 2019.

NGen Contributes to C$4.2m Canadian viral vector manufacturing project. Manufacturing Chemist, September 10, 2019.

Advanced Manufacturing Supercluster project kicks off with NGen funding. Canadian Manufacturing, August 22, 2019.

Advanced manufacturing supercluster invests in potentially life-saving gene therapies. U of T News, August 22, 2019.

Ontario’s Advanced Manufacturing Supercluster Announces First Project. BetaKit, August 21, 2019.

Big Red Oak honoured with 2019 video awards. Big Red Oak, August 7, 2019.

Gene-Editing Techniques Target New Applications. BioPharm International, August 1, 2019.

Designing production facilities of the future. BioPharma-Asia, July 30, 2019.

Process development of a closed CAR-T manufacturing process. BioProcess International, July 18, 2019.

These startups want to freeze your cells.  Medium’s Elemental, June 27, 2019.

Innovative Solutions from Industry 4.0. (Webinar) BioPharma-Asia, June, 10, 2019.

CCRM & the new CCVP facility: an interview with Director of Operations, Helen Pejnovich, P.EngSociety Notes, June 5, 2019.

Ontario companies fill marketplace voids. Biotechnology Focus, June 3, 2019.

Cell Therapy Manufacturing Under GMP – How And When To Get Started. Cell & Gene, May 2, 2019.

Are we moving towards a more automated CAR-T cell manufacturing process? RegMedNet, April 30, 2019.

Collaboration will drive regenerative medicine: Toronto development center will help to advance the field. BioProcess International, April 18, 2019.

Study reveals large molecular differences between stem cells grown on different biomaterials. Donnelly Centre website. April 15, 2019.

Michael May discusses the intersection of medical devices in regenerative medicine. StarFish Medical, Mar. 20, 2019.

GE Healthcare looks to spawn growth in regenerative medicine with CCRM partnership. Genetic Engineering & Biotechnology News, Jan. 31, 2019.

Federal government to defund Networks of Centres of Excellence. The Varsity, Jan. 29, 2019.

General Electric: The immunotherapy hurdle – and why doctors could soon predict how each patient will respond. Market Screener, Jan. 6, 2019.

Navigating the regulatory complexity of Regenerative Medicine in Canada. Biotechnology Focus, December 2018/January 2019 issue.

CCRM in the News 2018

A sampling of media coverage that profiles or mentions CCRM

MaRS: Innovate inclusively. Compete fiercely. MaRS Magazine, December 11, 2018.

De-mystifying and de-risking process development through early engagement with a CDMO. Cell & Gene, Nov. 27, 2018.

Tackling the talent gap in the cell and gene therapy industry. Signals and Biotechnology Focus, Nov. 10, 2018.

Get ready…get set…GMP and cell therapy. Genetic Engineering and Biotechnology News, Nov. 6, 2018.

New art and science exhibit at Pearson Airport. “Metro Morning with Matt Galloway,” CBC Radio, October 10, 2018.

Nontraditional pharma companies. PharmaVOICE.com, October 2018.

Artful Science exhibit takes off at Toronto Pearson Airport. The Varsity, September 30, 2018.

‘Summer camp for researchers’ aims to accelerate regenerative medicine discoveries into new therapies. U of T News, September 26, 2018.

A call for unity at TERMIS 2018. BMC Series Blog, September 24, 2018.

Take a high-flying trip to the heart of discovery. Research2Reality, September 21, 2018.

CCRM liaises to advance regenerative medicine internationally in Japan. Biotechnology Focus, September 7, 2018.

Canadian technology and innovation: making strides in the global cell therapy landscape. Biotechnology Focus, August 16, 2018.

Injectable Discogenic Cell Therapy Developed to Alleviate Back Pain. Technology Networks, August 6, 2018.

Federal government renews $15 million in funding for Toronto’s regenerative medicine cluster. U of T News, July 30, 2018.

The Government of Canada makes substantial investment of nearly $80-million. Biotechnology Focus, July 30, 2018.

Closed system cell therapy manufacturing – Moving from the lab to clinical and commercial production (podcast). The Cell Culture Dish, July 26, 2018.

Toronto added more tech jobs last year than Silicon Valley – or anywhere else in North America: Report. U of T News, July 26, 2018.

Supporting the Development of Regenerative Medicines. Technology Networks, July 6, 2018.

CCRM: Cultivating good health one stem cell treatment at a time. Society Notes – The official blog of the Ontario Society of Professional Engineers, June 27, 2018.

Medicine by Design researchers clear hurdles toward robust supply of stem cells for research and therapy. Medicine by Design website, June 6, 2018.

GE and CCRM partner with DiscGenics on new cell therapy. BioPharm International, May 31, 2018.

Navigating immunotherapies to Canada. Biotechnology Focus, May 18, 2018.

OSPE Supports Remarkable. Society Notes – The official blog of the Ontario Society of Professional Engineers, May 9, 2018.

A Cure for Investor Skepticism (article and video). Research2Reality, May 8, 2018.

Fixing the weak links in the cell therapy manufacturing chain: processes, people and partnerships. Cell and Gene Therapy Insights, April 25, 2018.

Hope beyond hype: The pursuit of longevity in stem cell therapies. Biotechnology Focus, April 27, 2018.

U of T conference explores the future of health care – and how Toronto will shape it. U of T News, April 13, 2018.

In Cold Blood: These Scientists Are Using Very, Very Cool Science To Fight Cancer. GE Reports, April 11, 2018.

A conversation with Peter Zandstra, PhD, FRSC(E). BCRedMed, April 10, 2018.

Fulfilling the Promise of Much-Needed Cures (article and video). Research2Reality, April 10, 2018.

Cell therapy production moves to factory floor. Genetic Engineering and Biotechnology News, March 15, 2018.

Toronto’s Centre for Advanced Therapeutic Cell Technologies Makes Its Mark on Regenerative Medicine. Lab Manager, March 8, 2018.

Industrial medicine: Cell therapy scales up. GE Reports, March 5, 2018.

Canadian biomedical engineers are bringing new advanced therapeutic products to Canadians. Biotechnology Focus, February 27, 2018.

Canada Eyes Leading Role in Regenerative Medicine (article and video). Research2Reality, February 20, 2018.

From stem cells to revenue: Bringing regenerative medicine to the masses. Financial Post, January 24, 2018.

Support of GE Healthcare to quicken CBMG’s cell therapy manufacturing. Pharmacy Choice, January 23, 2018.

Manufacturing medical marvels: How a new cell therapy platform helps scale up manufacturing to reach more patients. The Pulse, January 19, 2018.

Stem Cell Manufacturing: It’s All about Scale. Genetic Engineering and Biotechnology News, January 1, 2018.

CCRM in the News 2017

A sampling of media coverage that profiles or mentions CCRM

Repurposed drug could open door to more stem cell transplants. Technology Networks, December 21, 2017. 

A repurposed drug could be the key to successful stem cell transplants. Biotechnology Focus, December 20, 2017. 

Medicine by Design researchers seek to make blood stem cell transplants available to more patients. MbD, University of Toronto website. December 15, 2017. 

Stem Cells Meet AI in Quest to Mass-Produce Key Disease Fighters. Bloomberg, December 12, 2017.

The real health benefits of avocado. Chatelaine, November 30, 2017.

U of T Engineering celebrates industry collaborations and honours key partners. University of Toronto website, November 27, 2017.

Survivor: This woman’s battle with leukemia is pointing the way to the future of healthcare. GE Reports, November 22, 2017.

Japan faces new competition in the race for ‘regenerative medicine’. Nikkei Asian Review, November 8, 2017.

Canada Joins the CAR T-Cell Club. Alliance of Advanced BioMedical Engineering website. November 6, 2017.

New centre is tackling manufacturing challenge of cell therapy field. World Pharma Today, October 31, 2017.

The fast track for regenerative medicine. Biotechnology Focus, October 24, 2017.

Toronto makes pitch to be world’s ‘Stem Cell City’ with new, state-of-the-art lab. U of T News, October 12, 2017.

Race to Market: Collaborating to Accelerate Cell Therapy. The Pulse, October 12, 2017.

Blog: Finding Inspiration at Home and Abroad. MTPConnect website, October 9, 2017.

CCRM and Affigen Partner to Develop Personalized Therapeutics for B-Cell Lymphoma, Leukemia. Lymphoma News Today, October 6, 2017. 

When science meets innovation: cell therapies. Hudson Institute of Medical Research, October 4, 2017. 

New Center Helps Scientists Reprogram The Immune System To Kill Cancer. GE Reports, September 28, 2017.

BlueRock Therapeutics: A regenerative medicine game-changer. The Ontario Investment Office website, August 29, 2017.

BlueRock Therapeutics opens R&D and manufacturing hub in Toronto. Betakit.com, August 17, 2017.

Michael May of CCRM talks about how to make the perfect pitch [podcast]. Biotechnology Focus, July 25, 2017. 

U of T’s Creative Destruction Lab expands, focusing on regenerative medicine. U of T News, July 20, 2017.

Summer by Design draws emerging regenerative medicine leaders from around the world to U of T. Medicine by Design, University of Toronto website, July 16, 2017.

CCRM hosts BRM 2017, promotes innovation in regenerative medicine. Biotechnology Focus, July 14, 2017.

Advanced Therapies Investment Report 2017: The Challenges and Opportunities of the Advanced Therapy SectorPhacilitate, Biotech and Money co-publication. July 2017.

Stem cell conference at U of T to focus on entrepreneurship. U of T News, July 11, 2017.

Spotlight: Ontario’s Regenerative Medicine Pipeline. Biotechnology Focus, June 30, 2017.

Tissue engineering pioneer Michael Sefton to lead Medicine by Design as Executive Director. University of Toronto Faculty of Medicine News, June 28, 2017.

CRISPR: Emerging applications for genome editing technology. Technology Networks, June 26, 2017.

Forging Partnerships In Regenerative Medicine Helps Make Canada A World Leader. National Post – Media Planet, June 22, 2017.

The big guys are here to stay. Biotechnology Focus, June 20, 2017. 

What is BlueRock working on? Biotechnology Focus, June 15, 2017.

Top 10 Stem Cell Companies on the NASDAQ. INN Daily, June 14, 2017.

U of T research helps pave the way for an off-the-shelf supply of cells for immunotherapy. Medicine by Design, University of Toronto website, May 25, 2017.

OIRM 2016 Annual Report. OIRM website, May 25, 2017.

BlueRock: Canada’s stem cell contender on the journey from petri dish to clinical trial. Pharmaceutical-technology.com, May 22, 2017.

Streamlining Stem Cell Manufacturing. GEN, April 24, 2017.

$225M BlueRock Therapeutics “monster” a magnet for Canada’s biotech sector. Financial Post, April 10, 2017.

Ontario’s home-grown stem cell contender. Pharmacy Choice, March 21, 2017. 

Canada shoots for tech boost as Trump shuts doors. The Times of Israel, March 12, 2017. 

BrainStorm seeks early Health Canada nod for NurOwn treatment. Drug Delivery Business News, February 22, 2017. 

Observers urge care in earmarking funds for innovation clustersThe Hill Times, February 8, 2017. 

CCRM: Cultivating a culture of cooperation to advance the global regenerative medicine industry. RegMedNet, February 2, 2017.

Collaboration brings together MBA and PhD students to map regenerative medicine ecosystem. Medicine by Design, University of Toronto website. February 2, 2017. 

Une exposition sur les cellules souches au Musee du Fjord. Le Courrier de Saguenay, January 15, 2017.

CCRM in the News 2016

A sampling of media coverage that profiles or mentions CCRM

Multitiered approach to stem cell discoveries. MaRS Magazine, November 2016.

Molly Shoichet awarded 2016 Till & McCulloch Award. U of T News, October 6, 2016.

Peter Zandstra receives international recognition for outstanding contributions to the development and commercialization of stem cell-based therapies. IBBME, University of Toronto, October 3, 2016.

Canada: A legal market facing up to new challenges. Leaders League, September 26, 2016.

Special op/ed: Canada can lead the world in regenerative medicine – but it won’t happen without strategic investment. Signals, August 30, 2016.

The Future is STEM. STEM Magazine, August 2016 issue.

Doctors’ Notes: Why scientific breakthroughs take time to move from lab to bedside. The Toronto Star, August 8, 2016.

Visualizing the cell and gene therapy supply chain of the future, an interview with Phil Vanek. (Video) Cell & Gene Therapy Insights, summer 2016.

The C Word. Bio Business, July/August 2016 issue.

Preparing for a cell culturing industry. Pharmaceutical Commerce, July 19, 2016.

There isn’t A cure for cancer. There are 7.4 billion.* The Pulse, July 13, 2016.

Women in cell & gene therapy. Phacilitate, June 23, 2016.

The BridGE@CCRM: Where cell and gene therapies go mainstream. Biotechnology Focus, June 7, 2016.

The Pace of Progress in Heart Regeneration. Biotechnology Focus, June 6, 2016

Peter Zandstra named University Professor, U of T’s highest academic rank. U of T Engineering News, June 3, 2016.

MaRS Innovation & CCRM strike deals in Israel. Biotechnology Focus PODCAST, May 31, 2016.

Times Are Exponentially A-Changin’ – And You Haven’t Seen Anything Yet, Says The X Prize’s Peter Diamandis. GE Reports, May 17, 2016.

Taking the ‘wrinkles’ out of drug development. University of Toronto (Faculty of Dentistry), May 17, 2016.

Life Sciences Grows Up. Lexpert, May 9, 2016.

Mobility After Paralysis? Stem Cells Face Clinical Trials. Research2Reality.com, May 5, 2016.

Toronto, Canada, is the Site of New Centre for Advanced Therapeutic Cell Technologies. ISCT Telegraft, April 2016.

Corporate Partnerships On The Rise: The Toronto Opportunity. Life Science Nation, April 21, 2016.

Cutting-edge clinical trials in stem cell and regenerative medicine. Clinical Trials Ontario, April 20, 2016.

Collaboration will drive regenerative medicine: Toronto development center will help to advance the field. BioProcess International, April 18, 2016.

An engineering road map for scaling up production of stem cell-derived treatments. U of T Engineering News, April 7, 2016.

Canadian federal budget 2016: Research & innovation investment summary. Biotechnology Focus,March 23, 2016.

StemCellTalks inspires Toronto high school students with the promise of regenerative medicine. IBBME at U of T, March 14, 2016.

What does retirement mean when aging may soon be a thing of the past? Entrepreneur, Yahoo Finance,February 29, 2016.

Q&A with Michael May: New cell manufacturing centre will clear bottlenecks, attract clinical trials. Canadian Stem Cell Foundation, Feb. 25, 2016.

New Canadian biotech aims for a novel approach to blood cancer, rare disease. FierceBiotech,February 19, 2016.

Electrical imaging tells tales of the broken heart – and if a stem cell patch can fix it. Expression,February 11, 2016.

Canada Next: MaRS CEO on the future for startups. U of T News, February 2, 2016.

Canada’s stem cell research needs ‘big investment’ to move forward, experts say. CBC.ca, January 31, 2016.

Huge Opportunity For Gene Therapy Research At AnC Bio, Scientists Say. The Orleans Record, Jan. 30 and 31, 2016.

New centre, investment bolsters Ontario’s strength in stem cell technologies and regenerative medicine. Invest in Ontario, January 28, 2016.

Sernova Teams Up with CCRM. Contract Pharma, January 27, 2016.

MaRS Announcement, enGene Partnership, and McMaster Discoveries – EP 5. Biotechnology Focus (Podcast), January 19, 2016.

Canada Opening “International Hub For Stem Cell Therapy.” Futurism, January 18, 2016.

Trudeau announces $20-million in funding for Toronto stem cell researchGlobe and Mail, January 13, 2016.

Trudeau tours lab ahead of funding announcement (Video). CP24, January 13, 2016.

Prime Minister Justin Trudeau backs commercialization of stem cell research by U of T and partners. U of T News, January 13, 2016.

Ottawa to invest $20M in stem cell research. CTV News, January 13, 2016.

CCRM in the News 2015

A sampling of media coverage that profiles or mentions CCRM

Gene Therapy to Treat HIV in Clinical Trial. Forbes, December 31, 2015

From Bench to Business. Canadian Journal of Medical Laboratory Science,Winter 2015. 

Stem cells: latest development and potential therapeutics. Biotechin.Asia,December 15, 2015. 

Third Annual 24 Hours of Stem Cells Virtual Conference. The Cell Culture Dish,December 10, 2015. 

Body parts to go. Examiner.com,December 2, 2015.

Banking on cord blood. Biotechnology Focus, November 20, 2015.

Canadian researchers recognized for diabetes breakthrough using stem cells. Forbes,November 20, 2015.

Highlights from #TMM2015. McMaster University’s Stem Cell and Cancer Research Institute blog,November 13, 2015. 

Stem cell exhibit for kids is a hit with adults too. U of T News, November 10, 2015.

Regenerative medicine conference puts spotlight on Toronto. U of T News, October 30, 2015.

Where to Get Your Morning Stem Cell News? Top 15 Accounts to Follow on Twitter. BioInformant, October 28, 2015.

Canada’s emerging cell therapy biotech industry. Financial Post, October 27, 2015.

Canada’s regenerative medicine conference opens in Toronto. Biotechnology Focus, October 26, 2015.

Super Cells: The Power of stem cells exhibit for children at MaRS #Toronto. Teddy Out-Ready (parenting blog), October 21, 2015.

“Think Beyond a Single Batch” says Nick Timmins of CCRM. Future of Biopharma blog, October 21, 2015.

Timothy Kieffer to receive 2015 Till & McCulloch Award: Landmark Canadian paper advances knowledge to cure diabetes. Biotechnology Focus, October 16, 2015.

Analysis…Investing in the future [OIRM’s Dr. Janet Rossant on new $25M funding for stem cell research]. Pan European Networks: Science & Technology, Issue 16, October 12, 2015.

Equipment and resources are the key Bottlenecks in cell therapy commercialization. Future of Biopharma blog, October 2, 2015.

#TMM2015. McMaster University’s Stem Cell and Cancer Research Institute blog, October 2, 2015.

U of T research facilities to expand in new partnership. Lab Product News, September 15, 2015.

U of T Expands Research Facilities in New Partnership with MaRS. U of T News, September 2, 2015

Returning to Form: New funding gives hope for 10 new therapies over the next 10 years. Bio Business,Sept./Oct. 2015.

$1.5B research fund announces first successful funding recipients. Lab Product News, August 12, 2015.

Q&A: Paul Spagnuolo, Cancer and Avocados. Laboratory Equipment, July 30, 2015.

CCRM takes on commercialization role with “Medicine by Design” initiative. Biotechnology Focus, July 30, 2015.

Researchers hope $114-million grant will make Toronto a hub for stem cell research​. The Globe and Mail, July 28, 2015. 

Behind the scenes of Medicine by Design with Molly Shoichet [CCRM advisor] and Peter Zandstra [Chief Scientific Officer]. U of T Engineering News, July 28, 2015.

Banking on cord blood. Ontario Institute for Regenerative Medicine, summer 2015.

Venture capital investors are flocking to burgeoning biotech startups. Financial Post, June 24, 2015. 

Gregory Bonfiglio, Proteus Venture – Investing exclusively in Regenerative Medicine. PharmaTelevision, June 22, 2015.

Quebec: ExCellThera Veut Transformer la Greffe de Cellules Souches. BiotechFinances,22 juin 2015 N-686

Ontario invests $25 million in stem cell research. Biotechnology Focus, June 22, 2015.

Ontario’s biotechs in good company with CCRM’s industry consortium. Ontario Institute for Regenerative Medicine, summer 2015. 

Avocados could hold the key to helping beat rare form of leukemiaThe Independent, June 16, 2015.

IRICoR and CCRM partner to launch ExCellThera. Biotechnology Focus, June 15, 2015.

A perfect storm in regenerative medicine. Biotechnology Focus, June 3, 2015.

A collaborative approach to advance stem cell research and commercialization. Ontario Institute for Regenerative Medicine, summer 2015.

New Investment Funds and Network to Accelerate RM CommercializationBioteCanada: insights Magazine,Spring 2015.

How to Grow a Regenerative Medicine Industry in Canada: Michael May of CCRM. The Life Sciences Report,April 23, 2015.

Stem Cell Research Promises Health and Economic Benefits. Media Planet/National Post,March 21, 2015. 

Commercialized cell therapies goal of regenerative medicine alliance. Lab Product News,March 20, 2015. 

Seeking to cure the incurable: Canada and Japan setting the world pace for innovations in RM. Financial Post,March 10, 2015. 

Newcastle Hosts Major Interactive Science Exhibit Exploring the Wonder of Stem Cells. Pharmiweb.com,March 6, 2015. 

A Recipe for Life Sciences Commercialization. Life Science Leader, February 26, 2015. 

How Canada can capitalize on its stem cell technology advantage. Policy Options, February 18, 2015. 

CCRM in the News 2014

Ontario funds new regenerative medicine organization to speed commercialization. Re$earch Money, December 10, 2014.

New institute to study regenerative medicine. Lab Products News, Dec. 3, 2014.

Government of Ontario, OSCI and CCRM launch new regenerative medicine institute. Biotechnology Focus, Nov. 28, 2014.

L’Ontario soutient des travaux de recherche revolutionnaires sur les cellules souches. La gazette du Laboratoire, le 27 novembre, 2014.

Ontario announces funding for stem cell institute. The Globe and Mail, Nov. 25, 2015

Historic $130-million gift to establish the Ted Rogers Centre for Heart Research. U of T Engineering News, Nov. 20, 2014.

Super Cells exhibit and why we bother with public outreach. Knoepfler Lab Stem Cell Blog, Nov. 12, 2014.

New stem cell action plan promises major leap forward in alleviating human suffering. Biotechnology Focus, Nov. 6, 2014.

Ebola Watch: The Importance of Stopping Contamination. Laboratory Equipment, Nov. 6, 2014.

Medical groups call for $1.5B stem cell investment. CTV News, Oct. 29, 2014.

Coalition calls on Ottawa to commit $500M for stem cell research. The Globe and Mail, Oct. 29, 2014.

Video: New push for stem cell research funding. Global News, Oct. 29, 2014.

Medical groups call for major stem cell investment from public-private sector. CTV News, Oct. 29, 2014.

Ottawa hosts global leaders in stem cell and regenerative medicine research. Biotechnology Focus, Oct. 27, 2014.

Canadian Stem Cell Experts Gather for Till-McCulloch 2014. Forbes, Oct. 27, 2014.

Building Canada’s Strengths: Regenerative Medicine – Canada’s rise as an international powerhouse in stem cell research is no accident. nce-rce.gc.ca 2014

Highlights from the Business of Regenerative Medicine Course. Biotechnology Focus, Oct/Nov 2014.

The ethics of using stem cells for enhancement. JaneLangille.com, Oct. 14, 2014.

Building a superhuman: Stem cell advances are leading to dangers and ethical problems few have considered. Calgary Herald, Oct. 5, 2014.

Op-Ed: “Stem Cell Superheroes and the Limits of Our Biology” Special. Digital Journal, Oct. 4, 2014.

Partnering to build the global regenmed industry. Regen Magazine 2014.

Une nouvelle exposition sur les cellules souches au Musee de la nature et des sciences. Estrieplus.com, Sept. 29, 2014.

New compound developed for cord blood expansion. Lab Product News, Sept. 23, 2014.

CCRM and RepliCel partner on development of cell therapies for tendon repair. Biotechnology Focus, Sept. 8, 2014.

Cell Science Citizens: From the Petri Dish to the Clinic. The International Network for Knowledge about Wellbeing, Sept. 8, 2014.

Some academics worry if Canada’s commitment to fund commercial research over basic science will backfire (podcast). “The Current” from CBC Radio, Sept. 5, 2014.

CCRM uses ambr15 for Pluripotent Stem Cell Expansion and Differentiation Research. Lab Bulletin, August 21, 2014.

‘De-risking’ Stem Cell Therapy with Government Cash and Assistance. California Stem Cell Report blog, August 18, 2014.

Therapies of the state  Nature Biotechnology, August 05, 2014.

Thirteen more companies join CCRM’s industry consortium. Biotechnology Focus, July 25, 2014.

Cell Therapy Commercialization: Look for Headroom. BioteCanada Insights, Summer issue 2014.

BDC Capital Announces $500,000 Convertible Notes for Canadian Healthtech Startups. Now Digital Network, June 26, 2014.

New BDC-Backed Accel-Rx Health Sciences Accelerator Will Give Startups $500,000. BetaKit, June 25, 2014.

Culturing growth: How an idea from BC Cancer Agency grew into Canada’s biggest stem cell business venture. The Vancouver Sun, June 21, 2014.

Canada Australia to collaborate in stem cell research. Lab Product News, June 17, 2014.

The Real Deal on Stem Cell Therapies. Vancouver Magazine, June 17, 2014.

Panelists: Positives amid setbacks in cell therapy, regenerative medicine space. Bioworld Today, May 22, 2014.

The role of translational centers in regenerative medicine industryStem Cell Assays, May 21, 2014.

CCRM and Hemostemix to partner on developing cell therapies for cardiovascular disease. Biotechnology Focus, May 06, 2014.

California Stem Cell Institute Picks Industry Veteran as President. American Association for the Advancement of Science, April 30, 2014.

Podcast of Michael May on cell therapy reimbursement obstacles in the UK and North America. BioProcess International.

Stem cells donation campaign on [Humber] campus. Humber Et Cetera, March 14, 2014.

Opening the door to opportunity in Singapore and Japan. Biotechnology Focus, January 29, 2014.

The stem of the matter. Canadian Institute of Canada. January 2014.

CCRM in the News 2013

Stem Cell Blog of the Year 2013: Signals Blog by Stem Cell Network/CCRM. Knoepfler Lab Stem Cell Blog, December 10, 2013.

[Regener8] investigates translation the North American way. Regen, December 2013.

CCRM: Moving Forward with Regenerative Medicine Commercialization in Canada. Stem Cells and Development: World Stem Cell Report, Vol. 22, Issue S1.

Taking the pulse – indicators of strength and growth in the RM industry. Biotechnology Focus, November 25, 2013.

What composes the human heart? Researchers crunch the numbers. PHYS ORG, November 20, 2013.

IBBME Focal Point: Peter Zandstra (podcast). IBBME Focal Point, November 1, 2013

Collaboration and convergence – Indicators of strength and growth in RegenMed. Regen, October 2013, Issue 4.

Stem cells: how to predict their fate. U of T News, October 22, 2013. 

360ip and CCRM join forces to source best IP in regenerative medicine. Biotechnology Focus, October 17, 2013. 

[Peter Zandstra] behind Canadian stem cell technology recognized with Till & McCulloch Award. Biotechnology Focus, October 2, 2013.

Industry consortium key – New model aims to capitalize on Canada’s world-class strength in regenerative medicine. Re$earch Money, August 27, 2013.

Video of RM leaders, including CCRM’s Peter Zandstra, on the emergence of stem cell engineering. YouTube, August 13, 2013.

Interview [with Peter Zandstra]: The bioprocessing of stem cells: how to reach the clinic. Future Medicine: Regenerative Medicine, July 2013, Vol. 8

Setting the standard for cell therapy: Project update. Foreign and Commonwealth Office Blogs, June 25, 2013.

ISSCR 2013 Part 5: Centre for Commercialization of Regenerative Medicine. The Center for Medical Progress (video). June 21, 2013.

Cell therapy and regenerative medicine centres in Canada and UK to work together. Biotechnology Focus, June 10, 2013.

Guest blog: Predictive surrogate assays could drive efficient clinical translation and commercialization. BioPortfolio.com, June 5, 2013. 

Cell therapy and regenerative medicine centres in Canada and UK to collaborate. Manufacturing Chemist, May 31, 2013. 

Stem cell patents – Securing intellectual property for regenerative medicine. Biotechnology Focus, April 2013.

No frivolity here: 15 stem cell experts and 10 news sources to follow on Twitter. MEDCity News, April 5, 2013.

Multi-imaging stem cells in real time. Forbes, March 8, 2013.

Stem cell development companies could regenerate into higher profits in 2013. Market Playground, March 4, 2013.

Sernova and CCRM partner to treat chronic diseases. Biotechnology Focus, March 1, 2013.

CCRM implements ethics unit to promote responsible research. Laboratory Focus, February 25, 2013.

Insception, largest cord blood bank in Canada, joins CCRM Consortium. IBBME News, February 6, 2013.

Everything you Need [Toronto is a great biotech hub]. BioBusiness, Jan/Feb 2013.

Technologies evolving for cellular therapies. Genetic Engineering and Biotechnology News, Jan. 15, 2013.

CCRM in the News 2012

Integrating engineering and health care – It’s not all about technology. Engineering Dimensions, Nov/Dec 2012.

Global update: Canada. World Stem Cell Report, Regen. Med. 7(6 Suppl.) (2012)

Efforts to commercialize regenerative medicine in Canada growing steadily. Biotechnology Focus, December 2012, Vol. 15 #11

Regenerative medicine could experience growth spurt. The Newspaper, November 14, 2012. 

Tomorrow’s Technology: Regenerative Medicine. U of T News, October 30, 2012.

Biomedical symposium features local and international talent. Varsity, October 22, 2012.

Small and mighty: Stem cells hold great promise for CanadaNational Post (supplement), September 2012

Feds investing more in science and technology ‘than ever in the history of our nation,’ says Goodyear. Hill Times, September 10, 2012.

Canada’s life sciences industry split on Canada-EU free trade agreement. Hill Times, September 10, 2012.

It’s time to nurture an emerging Canadian regenerative medicine industry. Op-Ed by Michael May. Hill Times, September 10, 2012.

There’s Always a Way. IBBME, Innovators and Entrepreneurs, July 30, 2012.

U of T Engineering Professor [CCRM’s Peter Zandstra] Joins International Advisory Committee. U of T News, July 12, 2012.

CCRM – Strategic Partnerships Are Paying Off. Biotechnology Focus, July 2012.

OSCI: The Ties That Bind. Biotechnology Focus, July 2012.

Inventors of the Year. U of T News, June 11, 2012.

Scientists learn how to turn skin cells into heart muscle. Canada AM (CTV), May 23, 2012. 

Stem cells to optimize match between patient and medication. Financial Post (Smart Shift series), May 15, 2012. 

Reasons to LOVE Toronto Now. Toronto Life, June 2012.

Collaboration Will Create Disruption in Regenerative Medicine. Business Strategy blog, May 13, 2012.

Toronto: Canada’s startup and entrepreneurial capital. U of T News, May 1, 2012.

New fund for regenerative medicine industry. Benefits Canada, May 1, 2012.

VistaGen Therapeutics takes part in international collaborative medicine effort. MissionIR, March 30, 2012.

Toronto non-profit and Millipore collaborate to design stem cell bioreactor. TechVibes, March 13, 2012.  

Millipore and Toronto non-profit cultivate stem cells in bioreactor. Mass High Tech, March 12, 2012.

EMD Millipore, CCRM optimize large-scale stem cell cultivation. Genetic Engineering & Biotechnology News, March 12, 2012.

EMD Millipore and CCRM collaborate on stem cell cultivation. Patexia, March 13, 2012.

Large-scale stem cell cultivation partnership formalized. U of T News, March 6, 2012. 

CCRM in the News 2011

Innovation hub forming in Banting and Best complex. U of T Research & Innovation, October 12, 2011.

Commercialisation of Regenerative Medicine. Pharma IQ, September 20, 2011.

OSCI and CCRM: ensuring Ontario’s regenerative medicine legacy lives on. Biotechnology Focus, June 2011, Vol. 14, Number 6.

Font Resize
Enable Contrast